BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23249969)

  • 1. Nononcological applications of positron emission tomography for evaluation of the thorax.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):25-39. PubMed ID: 23249969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological applications of positron emission tomography for evaluation of the thorax.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):11-24. PubMed ID: 23249968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
    Wachsmann JW; Gerbaudo VH
    PET Clin; 2014 Apr; 9(2):147-68. PubMed ID: 25030279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography imaging in nonmalignant thoracic disorders.
    Alavi A; Gupta N; Alberini JL; Hickeson M; Adam LE; Bhargava P; Zhuang H
    Semin Nucl Med; 2002 Oct; 32(4):293-321. PubMed ID: 12524653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises.
    Kalshetty A; Basu S
    PET Clin; 2020 Apr; 15(2):163-173. PubMed ID: 32145887
    [No Abstract]   [Full Text] [Related]  

  • 7. FDG-PET/CT in Infectious and Inflammatory Diseases.
    Hess S; Hansson SH; Pedersen KT; Basu S; Høilund-Carlsen PF
    PET Clin; 2014 Oct; 9(4):497-519, vi-vii. PubMed ID: 26050949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
    Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
    Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in chronic obstructive pulmonary disease.
    Madsen PH; Hess S; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2013; 16(2):121-4. PubMed ID: 23865084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders.
    El-Haddad G; Zhuang H; Gupta N; Alavi A
    Semin Nucl Med; 2004 Oct; 34(4):313-29. PubMed ID: 15493008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract]   [Full Text] [Related]  

  • 12. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
    Li D; Lü PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
    [No Abstract]   [Full Text] [Related]  

  • 13. PET imaging approaches for inflammatory lung diseases: Current concepts and future directions.
    Chen DL; Schiebler ML; Goo JM; van Beek EJR
    Eur J Radiol; 2017 Jan; 86():371-376. PubMed ID: 27663638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced imaging of cardiac sarcoidosis.
    Schatka I; Bengel FM
    J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert opinion: how can quantitative CT benefit patients with COPD and idiopathic interstitial pneumonias?
    Boiselle PM; Crapo JD; Han MK; Lynch DA; Tashkin DP
    J Thorac Imaging; 2013 Sep; 28(5):263. PubMed ID: 23934143
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging the inflammatory activity of sarcoidosis.
    Keijsers RG; van den Heuvel DA; Grutters JC
    Eur Respir J; 2013 Mar; 41(3):743-51. PubMed ID: 23018903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography.
    Marie I; Lahaxe L; Vera P; Edet-Samson A
    QJM; 2010 Dec; 103(12):1000-2. PubMed ID: 20385567
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorodeoxyglucose F 18 positron emission tomography scanning in thoracic disease.
    Fahy RJ; King M
    South Med J; 2004 Dec; 97(12):1156-7. PubMed ID: 15646749
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease.
    Daouk J; Bailly P; Kamimura M; Sacksick D; Jounieaux V; Meyer ME
    Ann Nucl Med; 2015 May; 29(4):319-24. PubMed ID: 25567204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)-F-fluorodeoxyglucose positron emission tomography/computed tomography study in acute lung injury/acute respiratory distress syndrome.
    Rodrigues RS; Carvalho AR; Morton KA; Bozza FA
    Crit Care Med; 2010 Jan; 38(1):347-8; author reply 348. PubMed ID: 20023508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.